Planned Parenthood Los Angeles Van Nuys Center
Planned Parenthood Los Angeles Van Nuys Center was paid $5.30M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 12% of everything it billed.
VAN NUYS, CA 91405
Next to other Community Health Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,308 | $1.15M | |
| 2019 | 12,431 | $729K | |
| 2020 | 9,327 | $481K | |
| 2021 | 12,337 | $717K | |
| 2022 | 8,801 | $523K | |
| 2023 | 14,870 | $924K | |
| 2024incomplete | 10,998 | $779K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 12% | 679 | 677 | $653K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.4% | 2,550 | 2,462 | $499K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.9% | 1,485 | 1,439 | $472K |
| S4993 | Contraceptive pills for birth control | 8.5% | 4,955 | 4,940 | $450K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.5% | 3,519 | 3,310 | $449K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.4% | 7,190 | 6,346 | $448K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.7% | 4,243 | 4,108 | $410K |
| J3490 | Unclassified drugs | 7.6% | 10,757 | 9,378 | $403K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.8% | 1,656 | 1,633 | $309K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 496 | 496 | $196K |
| 11981 | 3.2% | 670 | 670 | $170K | |
| 87806 | 2.2% | 4,675 | 3,683 | $117K |
34 more codes
| 58300 | 2.0% | 1,030 | $107K | |
| 99201 | 1.6% | 705 | $85K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.4% | 107 | $73K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 1.1% | 120 | $60K |
| 81025 | <1% | 12,196 | $52K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 5,480 | $38K |
| 11976 | <1% | 575 | $36K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,580 | $33K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 40 | $29K |
| 99401 | <1% | 1,525 | $29K | |
| S5000 | Prescription drug, generic | <1% | 3,297 | $24K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 245 | $23K |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 76 | $19K |
| 58301 | <1% | 602 | $18K | |
| 83986 | <1% | 5,316 | $14K | |
| 99000 | <1% | 3,696 | $13K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 3,133 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 378 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 369 | $10K |
| 86703 | <1% | 682 | $7K | |
| 99402 | <1% | 204 | $6K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 92 | $6K |
| 99403 | <1% | 114 | $5K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 99 | $5K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 974 | $4K |
| 81002 | <1% | 1,241 | $2K | |
| 85018 | <1% | 317 | $1K | |
| 86592 | <1% | 355 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 58 | $1K |
| 82120 | <1% | 197 | $712.77 | |
| 87210 | <1% | 199 | $697.12 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 63 | $339.90 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 119 | $291.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $64.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.